USA Oral Vaccines Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Oral Vaccines market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Oral Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by Oral Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Merck

    • Tiantan Biological

    • GSK

    • Panacea Biotec Ltd

    • Shanghai United Cell

    • Valneva

    • Serum Institute

    • Halfkin Bio-Pharmaceuticals

    • Vabiotech

    • Bibcol

    • Bio-Med

    • EuBiologics

    • Lanzhou Institute

    • PaxVax

    • Sanofi

    By Type:

    • Rotavirus Vaccine

    • Cholera Vaccine

    • Oral Polio Vaccine

    • Others

    By End-User:

    • Public

    • Private

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oral Vaccines Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Oral Vaccines Market Size and Growth Rate of Rotavirus Vaccine from 2016 to 2027

      • 1.3.2 USA Oral Vaccines Market Size and Growth Rate of Cholera Vaccine from 2016 to 2027

      • 1.3.3 USA Oral Vaccines Market Size and Growth Rate of Oral Polio Vaccine from 2016 to 2027

      • 1.3.4 USA Oral Vaccines Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Oral Vaccines Market Size and Growth Rate of Public from 2016 to 2027

      • 1.4.2 USA Oral Vaccines Market Size and Growth Rate of Private from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Oral Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Oral Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Oral Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Oral Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Oral Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oral Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of Rotavirus Vaccine

      • 3.4.2 Market Size and Growth Rate of Cholera Vaccine

      • 3.4.3 Market Size and Growth Rate of Oral Polio Vaccine

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Oral Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oral Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oral Vaccines in Public

      • 4.4.2 Market Size and Growth Rate of Oral Vaccines in Private

    5 Market Analysis by Regions

    • 5.1 USA Oral Vaccines Production Analysis by Regions

    • 5.2 USA Oral Vaccines Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Oral Vaccines Landscape Analysis

    • 6.1 West USA Oral Vaccines Landscape Analysis by Major Types

    • 6.2 West USA Oral Vaccines Landscape Analysis by Major End-Users

    7 South USA Oral Vaccines Landscape Analysis

    • 7.1 South USA Oral Vaccines Landscape Analysis by Major Types

    • 7.2 South USA Oral Vaccines Landscape Analysis by Major End-Users

    8 Middle West USA Oral Vaccines Landscape Analysis

    • 8.1 Middle West USA Oral Vaccines Landscape Analysis by Major Types

    • 8.2 Middle West USA Oral Vaccines Landscape Analysis by Major End-Users

    9 Northeast USA Oral Vaccines Landscape Analysis

    • 9.1 Northeast USA Oral Vaccines Landscape Analysis by Major Types

    • 9.2 Northeast USA Oral Vaccines Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Merck

        • 10.1.1 Merck Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Tiantan Biological

        • 10.2.1 Tiantan Biological Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 GSK

        • 10.3.1 GSK Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Panacea Biotec Ltd

        • 10.4.1 Panacea Biotec Ltd Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Shanghai United Cell

        • 10.5.1 Shanghai United Cell Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Valneva

        • 10.6.1 Valneva Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Serum Institute

        • 10.7.1 Serum Institute Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Halfkin Bio-Pharmaceuticals

        • 10.8.1 Halfkin Bio-Pharmaceuticals Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Vabiotech

        • 10.9.1 Vabiotech Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Bibcol

        • 10.10.1 Bibcol Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Bio-Med

        • 10.11.1 Bio-Med Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 EuBiologics

        • 10.12.1 EuBiologics Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Lanzhou Institute

        • 10.13.1 Lanzhou Institute Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 PaxVax

        • 10.14.1 PaxVax Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Sanofi

        • 10.15.1 Sanofi Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Oral Vaccines Market Size and Growth Rate of Rotavirus Vaccine from 2016 to 2027

    • Figure USA Oral Vaccines Market Size and Growth Rate of Cholera Vaccine from 2016 to 2027

    • Figure USA Oral Vaccines Market Size and Growth Rate of Oral Polio Vaccine from 2016 to 2027

    • Figure USA Oral Vaccines Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Oral Vaccines Market Size and Growth Rate of Public from 2016 to 2027

    • Figure USA Oral Vaccines Market Size and Growth Rate of Private from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Oral Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Oral Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Oral Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Oral Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Oral Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Oral Vaccines

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oral Vaccines by Different Types from 2016 to 2027

    • Table Consumption Share of Oral Vaccines by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Rotavirus Vaccine

    • Figure Market Size and Growth Rate of Cholera Vaccine

    • Figure Market Size and Growth Rate of Oral Polio Vaccine

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Oral Vaccines by Different End-Users from 2016 to 2027

    • Table Consumption Share of Oral Vaccines by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Public

    • Figure Market Size and Growth Rate of Private

    • Table USA Oral Vaccines Production by Regions

    • Table USA Oral Vaccines Production Share by Regions

    • Figure USA Oral Vaccines Production Share by Regions in 2016

    • Figure USA Oral Vaccines Production Share by Regions in 2021

    • Figure USA Oral Vaccines Production Share by Regions in 2027

    • Table USA Oral Vaccines Consumption by Regions

    • Table USA Oral Vaccines Consumption Share by Regions

    • Figure USA Oral Vaccines Consumption Share by Regions in 2016

    • Figure USA Oral Vaccines Consumption Share by Regions in 2021

    • Figure USA Oral Vaccines Consumption Share by Regions in 2027

    • Table West USA Oral Vaccines Consumption by Types from 2016 to 2027

    • Table West USA Oral Vaccines Consumption Share by Types from 2016 to 2027

    • Figure West USA Oral Vaccines Consumption Share by Types in 2016

    • Figure West USA Oral Vaccines Consumption Share by Types in 2021

    • Figure West USA Oral Vaccines Consumption Share by Types in 2027

    • Table West USA Oral Vaccines Consumption by End-Users from 2016 to 2027

    • Table West USA Oral Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Oral Vaccines Consumption Share by End-Users in 2016

    • Figure West USA Oral Vaccines Consumption Share by End-Users in 2021

    • Figure West USA Oral Vaccines Consumption Share by End-Users in 2027

    • Table South USA Oral Vaccines Consumption by Types from 2016 to 2027

    • Table South USA Oral Vaccines Consumption Share by Types from 2016 to 2027

    • Figure South USA Oral Vaccines Consumption Share by Types in 2016

    • Figure South USA Oral Vaccines Consumption Share by Types in 2021

    • Figure South USA Oral Vaccines Consumption Share by Types in 2027

    • Table South USA Oral Vaccines Consumption by End-Users from 2016 to 2027

    • Table South USA Oral Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Oral Vaccines Consumption Share by End-Users in 2016

    • Figure South USA Oral Vaccines Consumption Share by End-Users in 2021

    • Figure South USA Oral Vaccines Consumption Share by End-Users in 2027

    • Table Middle West USA Oral Vaccines Consumption by Types from 2016 to 2027

    • Table Middle West USA Oral Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Oral Vaccines Consumption Share by Types in 2016

    • Figure Middle West USA Oral Vaccines Consumption Share by Types in 2021

    • Figure Middle West USA Oral Vaccines Consumption Share by Types in 2027

    • Table Middle West USA Oral Vaccines Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Oral Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Oral Vaccines Consumption Share by End-Users in 2016

    • Figure Middle West USA Oral Vaccines Consumption Share by End-Users in 2021

    • Figure Middle West USA Oral Vaccines Consumption Share by End-Users in 2027

    • Table Northeast USA Oral Vaccines Consumption by Types from 2016 to 2027

    • Table Northeast USA Oral Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Oral Vaccines Consumption Share by Types in 2016

    • Figure Northeast USA Oral Vaccines Consumption Share by Types in 2021

    • Figure Northeast USA Oral Vaccines Consumption Share by Types in 2027

    • Table Northeast USA Oral Vaccines Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Oral Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Oral Vaccines Consumption Share by End-Users in 2016

    • Figure Northeast USA Oral Vaccines Consumption Share by End-Users in 2021

    • Figure Northeast USA Oral Vaccines Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Tiantan Biological

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tiantan Biological

    • Figure Sales and Growth Rate Analysis of Tiantan Biological

    • Figure Revenue and Market Share Analysis of Tiantan Biological

    • Table Product and Service Introduction of Tiantan Biological

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Panacea Biotec Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Panacea Biotec Ltd

    • Figure Sales and Growth Rate Analysis of Panacea Biotec Ltd

    • Figure Revenue and Market Share Analysis of Panacea Biotec Ltd

    • Table Product and Service Introduction of Panacea Biotec Ltd

    • Table Company Profile and Development Status of Shanghai United Cell

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai United Cell

    • Figure Sales and Growth Rate Analysis of Shanghai United Cell

    • Figure Revenue and Market Share Analysis of Shanghai United Cell

    • Table Product and Service Introduction of Shanghai United Cell

    • Table Company Profile and Development Status of Valneva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valneva

    • Figure Sales and Growth Rate Analysis of Valneva

    • Figure Revenue and Market Share Analysis of Valneva

    • Table Product and Service Introduction of Valneva

    • Table Company Profile and Development Status of Serum Institute

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute

    • Figure Sales and Growth Rate Analysis of Serum Institute

    • Figure Revenue and Market Share Analysis of Serum Institute

    • Table Product and Service Introduction of Serum Institute

    • Table Company Profile and Development Status of Halfkin Bio-Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Halfkin Bio-Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Halfkin Bio-Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Halfkin Bio-Pharmaceuticals

    • Table Product and Service Introduction of Halfkin Bio-Pharmaceuticals

    • Table Company Profile and Development Status of Vabiotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vabiotech

    • Figure Sales and Growth Rate Analysis of Vabiotech

    • Figure Revenue and Market Share Analysis of Vabiotech

    • Table Product and Service Introduction of Vabiotech

    • Table Company Profile and Development Status of Bibcol

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bibcol

    • Figure Sales and Growth Rate Analysis of Bibcol

    • Figure Revenue and Market Share Analysis of Bibcol

    • Table Product and Service Introduction of Bibcol

    • Table Company Profile and Development Status of Bio-Med

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio-Med

    • Figure Sales and Growth Rate Analysis of Bio-Med

    • Figure Revenue and Market Share Analysis of Bio-Med

    • Table Product and Service Introduction of Bio-Med

    • Table Company Profile and Development Status of EuBiologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EuBiologics

    • Figure Sales and Growth Rate Analysis of EuBiologics

    • Figure Revenue and Market Share Analysis of EuBiologics

    • Table Product and Service Introduction of EuBiologics

    • Table Company Profile and Development Status of Lanzhou Institute

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lanzhou Institute

    • Figure Sales and Growth Rate Analysis of Lanzhou Institute

    • Figure Revenue and Market Share Analysis of Lanzhou Institute

    • Table Product and Service Introduction of Lanzhou Institute

    • Table Company Profile and Development Status of PaxVax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PaxVax

    • Figure Sales and Growth Rate Analysis of PaxVax

    • Figure Revenue and Market Share Analysis of PaxVax

    • Table Product and Service Introduction of PaxVax

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.